NFKB1 and colitis: Christian F et al. found that the NF-κB signaling pathway in UC and colitis-associated colon cancer mice models was increased, which will lead to pathological changes in the UC intestine and trigger positive feedback for further NF-κB activation and exacerbated inflammation [12].